FIELD: medicine.
SUBSTANCE: quantitative determination in vitro of basic fibroblast growth factor (bFGF) and human vascular endothelium growth factor (VEGF) in patient's blood serum is carried out by method of ELISA. If VEGF values are 185.66+33.5 pg/ml, bFGF 35.84±2.02 and more pg/ml, fast development and aggressive course of disease, bad response to carried out therapy are predicted. If VEGF values are 72.67±12.3 pg/ml, bFGF 34.06+2.59 pg/ml, slow development and benign course of disease are predicted.
EFFECT: application of invention increases accuracy of estimation of disease development and course, realises prognosis of bad response to carried out therapy in patients with chronic lympholeukemia.
2 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL FORM OF CHRONIC LYMPHOLEUKAEMIA | 2012 |
|
RU2490642C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT AND FLOW OF CHRONIC LYMPHOLEUKOSIS | 2003 |
|
RU2248574C1 |
| METHOD FOR PREDICTING THE COURSE OF CHRONIC LYMPHOCYTIC LEUKEMIA | 2022 |
|
RU2788816C1 |
| METHOD FOR PREDICTING THE FLOW OF CHRONIC LYMPHOLEUKOSIS | 2004 |
|
RU2256921C1 |
| METHOD FOR PREDICTION CHEMOTHERAPEUTIC RESPONSE IN CHRONIC LYMPHATIC LEUKAEMIA | 2012 |
|
RU2495427C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BENIGN AND PROGRESSIVE FORMS OF CHRONIC LYMPHOLEUKOSIS | 2003 |
|
RU2242004C1 |
| METHOD FOR PREDICTION OF SMOULDERING FORM OF CHRONIC LYMPHOLEUKAEMIA | 2012 |
|
RU2496110C1 |
| METHOD FOR PROGNOSIS OF MULTIPLE MYEOLOMA COURSE | 2002 |
|
RU2225612C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF LIFE-THREATENING AURICULAR ARRYTHMIA IN PATIENTS WITH HYPERTENSION DISEASE | 2016 |
|
RU2634246C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF NEUROLOGICAL COMPLICATIONS IN ADULT PATIENTS WITH ERYTHEMIC FORM OF IXODID TICK BORREOLISIS | 2015 |
|
RU2611354C1 |
